Ferrannini E - Search Results

1

Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial.

Ferrannini E, Ramos SJ, Salsali A, Tang W, List JF. Ferrannini E, et al. Diabetes Care. 2010 Oct;33(10):2217-24. doi: 10.2337/dc10-0612. Epub 2010 Jun 21. Diabetes Care. 2010. PMID: 20566676 Free PMC article. Clinical Trial.

2

Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes.

Iozzo P, Hallsten K, Oikonen V, Virtanen KA, Parkkola R, Kemppainen J, Solin O, Lonnqvist F, Ferrannini E, Knuuti J, Nuutila P. Iozzo P, et al. Among authors: ferrannini e. Diabetes Care. 2003 Jul;26(7):2069-74. doi: 10.2337/diacare.26.7.2069. Diabetes Care. 2003. PMID: 12832315

3

Mode of onset of type 2 diabetes from normal or impaired glucose tolerance.

Ferrannini E, Nannipieri M, Williams K, Gonzales C, Haffner SM, Stern MP. Ferrannini E, et al. Diabetes. 2004 Jan;53(1):160-5. doi: 10.2337/diabetes.53.1.160. Diabetes. 2004. PMID: 14693710

4

Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes.

Natali A, Baldeweg S, Toschi E, Capaldo B, Barbaro D, Gastaldelli A, Yudkin JS, Ferrannini E. Natali A, et al. Among authors: ferrannini e. Diabetes Care. 2004 Jun;27(6):1349-57. doi: 10.2337/diacare.27.6.1349. Diabetes Care. 2004. PMID: 15161787 Clinical Trial.

5

Effect of training status on regional disposal of circulating free fatty acids in the liver and skeletal muscle during physiological hyperinsulinemia.

Iozzo P, Takala T, Oikonen V, Bergman J, Grönroos T, Ferrannini E, Nuutila P, Knuuti J. Iozzo P, et al. Among authors: ferrannini e. Diabetes Care. 2004 Sep;27(9):2172-7. doi: 10.2337/diacare.27.9.2172. Diabetes Care. 2004. PMID: 15333480

6

Beta-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinide.

Mari A, Gastaldelli A, Foley JE, Pratley RE, Ferrannini E. Mari A, et al. Among authors: ferrannini e. Diabetes Care. 2005 May;28(5):1132-8. doi: 10.2337/diacare.28.5.1132. Diabetes Care. 2005. PMID: 15855578 Clinical Trial.

7

Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.

Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, Haffner SM, Stern MP, Ferrannini E; Mexico City diabetes study. Nannipieri M, et al. Among authors: ferrannini e. Diabetes Care. 2005 Jul;28(7):1757-62. doi: 10.2337/diacare.28.7.1757. Diabetes Care. 2005. PMID: 15983331

8

Hepatitis C virus infection: evidence for an association with type 2 diabetes.

Antonelli A, Ferri C, Fallahi P, Pampana A, Ferrari SM, Goglia F, Ferrannini E. Antonelli A, et al. Among authors: ferrannini e. Diabetes Care. 2005 Oct;28(10):2548-50. doi: 10.2337/diacare.28.10.2548. Diabetes Care. 2005. PMID: 16186298 Free article. No abstract available.

9

The effect of rosiglitazone on the liver: decreased gluconeogenesis in patients with type 2 diabetes.

Gastaldelli A, Miyazaki Y, Pettiti M, Santini E, Ciociaro D, Defronzo RA, Ferrannini E. Gastaldelli A, et al. Among authors: ferrannini e. J Clin Endocrinol Metab. 2006 Mar;91(3):806-12. doi: 10.1210/jc.2005-1159. Epub 2005 Dec 13. J Clin Endocrinol Metab. 2006. PMID: 16352689 Clinical Trial.

10

Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.

Natali A, Toschi E, Baldeweg S, Ciociaro D, Favilla S, Saccà L, Ferrannini E. Natali A, et al. Among authors: ferrannini e. Diabetes. 2006 Apr;55(4):1133-40. doi: 10.2337/diabetes.55.04.06.db05-1076. Diabetes. 2006. PMID: 16567539

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

772 results

Search Page

Filters